Lise Bech Jellesmark T.
- Country
- Denmark
- Department
- Department of Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 4 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in treating advanced esophageal squamous cell carcinoma, with particular attention to developing targeted therapeutic approaches that combine immunotherapy with standard treatments.
- HER2-positive esophageal cancer management
- Combined chemo-immunotherapy approaches
- First-line treatment strategies
Their research explores innovative treatment combinations incorporating targeted therapies with established therapeutic protocols.
Hepatobiliary Oncology
The investigator focuses on advancing treatment options for biliary tract cancers, including both intrahepatic and extrahepatic manifestations. Their work encompasses post-surgical therapeutic interventions for cholangiocarcinoma and gallbladder cancer.
- Adjuvant therapy optimization
- Novel therapeutic combinations
- Post-surgical cancer recurrence prevention
Their expertise extends to developing treatment strategies that aim to improve recurrence-free survival in surgically treated patients.
Precision Medicine
The investigator develops personalized treatment approaches incorporating targeted biological therapies with conventional treatment modalities. Their work emphasizes patient-specific therapeutic strategies based on molecular markers.
- Biomarker-driven treatment selection
- Molecular targeting strategies
- Combination therapy optimization
Their research integrates molecular diagnostics with therapeutic decision-making to enhance treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.